Understanding Patient Engagement Trends in Anxiety Disorder Clinical Research

Clinical trials, specifically focused on anxiety disorder, are crucial in assessing the safety and efficacy of new treatments. These trials serve as fundamental instruments in determining whether emerging medications outperform standard therapies, providing compelling evidence to support wider implementation.

The main goal is to thoroughly scrutinize trial completion rates and voluntary withdrawals among this particular group of patients.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Anxiety Disorder Anxiety Disorders Mental Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Power Life Sciences

San Francisco, California, 94107, United States

Location contact

Michael B Gill

CONTACT

https://www.withpower.com/[email protected]

415-900-4227

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged ≥ 18 years old
Diagnosis of anxiety disorder
Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion criteria

Female patients who are currently pregnant or nursing
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Inability to perform regular electronic reporting

Treatment and study plan

Primary outcomes

Number of anxiety disorder patients who decide to enroll in a clinical research

Time frame: 3 months
Rate of anxiety disorder patients who remain in clinical trial to trial completion

Time frame: 12 months

Study contacts

Contact information is provided by the study sponsor or research team.

Michael B Gill

CONTACT

[email protected]

415-900-4227

Sponsors and collaborators

Lead sponsor

Power Life Sciences Inc.

Industry

Registry information

Official study title

Investigating Patterns in Enrollment and Engagement Among Individuals Coping With Anxiety Disorder

Important dates

Study start: 2024
Primary completion: 2025
Study completion: 2026
First posted: Dec 4, 2023
Registry last updated: Dec 4, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting